Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England

• Main Authors: Dr Deborah Cromer, PhD (Author), Albert Jan van Hoek, PhD (Author), Anthony T Newall, PhD (Author), Andrew J Pollard, FMedSci (Author), Mark Jit, PhD (Author)
• Format: Book
• Published: Elsevier, 2017-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Vaccines and prophylactic antibodies against respiratory syncytial virus (RSV) are in development and likely to be available in the next 5-10 years. The most efficient way to use these products when they become available is an important consideration for public health decision makers. Me...